Krystal Biotech, Inc. KRYS Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $496.3M+43.9% | $344.87M-3.8% | $358.33M+121% | $161.9M-52.6% | ||
| $331.49M+31.2% | $252.65M+45.3% | $173.85M-20.0% | $217.27M+124% | ||
| $471.76M+15.1% | $410.03M+698% | $51.36M— | —— | ||
| $139.09M+104% | $68.31M+419% | $13.17M— | —— | ||
| $1.02B+38.1% | $742.05M+26.2% | $587.91M+53.2% | $383.78M-13.2% | ||
| $150.78M-2.8% | $155.17M-3.7% | $161.2M-0.3% | $161.68M+43.9% | ||
| $1.33B+26.3% | $1.06B+29.0% | $818.36M+46.5% | $558.45M-10.8% | ||
| $3.24M-35.0% | $4.99M+20.6% | $4.13M+3.8% | $3.98M-52.6% | ||
| $102.94M+0.9% | $102M+208% | $33.09M+14.7% | $28.85M+12.1% | ||
| $114.23M+4.4% | $109.46M+176% | $39.71M+9.6% | $36.22M+10.7% | ||
| 80M— | 0— | 0— | 0— | ||
| $24.16M+113% | -$180.67M+33.0% | -$269.83M+3.9% | -$280.76M-99.4% | ||
| $1.22B+28.9% | $946.38M+21.5% | $778.64M+49.1% | $522.23M-12.0% | ||
| $1.33B+26.3% | $1.06B+29.0% | $818.36M+46.5% | $558.45M-10.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Krystal Biotech, Inc.'s total assets?
- Krystal Biotech, Inc. (KRYS) holds $1.4B in total assets, up 30.0% year over year.
- How much debt does Krystal Biotech, Inc. have?
- Krystal Biotech, Inc. carries $9.1M in total debt against $1.3B of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Krystal Biotech, Inc. have?
- Krystal Biotech, Inc. holds $501.3M in cash and equivalents.
- Can Krystal Biotech, Inc. cover its short-term obligations?
- Its current ratio is 9.46 — current assets exceed current liabilities.
- Where does Krystal Biotech, Inc.'s balance sheet data come from?
- Every line is extracted from Krystal Biotech, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
